Akkaraju Srinivas's Form 4 filing
LENZ Therapeutics, Inc. (LENZ) · filed Dec 20, 2021
- Accession no.
- 0001209191-21-070500
- Filed
- Dec 20, 2021, 1:46 PM ET
- Trade date
- Dec 15, 2021
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $227.5K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Akkaraju SrinivasCIK 0001253170 | 10% Owner |
| Samsara BioCapital, L.P.CIK 0001699737 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 | Common Stock | PPurchaseAcquired | +22,329 | $10.19 | +$227,532.51 | 7,814,180 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.